Patent classifications
A61K36/24
PHYTONUTRIENT COMPOSITIONS ABLE TO LOWER POSTPRANDIAL BLOOD-GLUCOSE LEVELS THROUGH REGULATION OF SIGNAL TRANSDUCTION CASCADES
Described, among other things, are dosage form for administration to a subject, the dosage forms having at least four ingredients selected from okra, quercetin, gypenosides from Gynostemma pentaphyllum, punicalagins from pomegranate, zinc gluconate, chromium picolinate, curcuminoids, cinnamon Ceylon, mangiferin, Gymnema sylvestre extract, Schisandra chinensis, bitter melon, and Costus igneus. Upon administration to a mammalian subject, the dosage forms generally promote the subject's health through the maintenance of a healthy blood sugar level.
PHYTONUTRIENT COMPOSITIONS ABLE TO LOWER POSTPRANDIAL BLOOD-GLUCOSE LEVELS THROUGH REGULATION OF SIGNAL TRANSDUCTION CASCADES
Described, among other things, are dosage form for administration to a subject, the dosage forms having at least four ingredients selected from okra, quercetin, gypenosides from Gynostemma pentaphyllum, punicalagins from pomegranate, zinc gluconate, chromium picolinate, curcuminoids, cinnamon Ceylon, mangiferin, Gymnema sylvestre extract, Schisandra chinensis, bitter melon, and Costus igneus. Upon administration to a mammalian subject, the dosage forms generally promote the subject's health through the maintenance of a healthy blood sugar level.
Composition for and Method of Treating Neurological Conditions
A method of treating neurological condition in a subject by administration of a pharmaceutical composition that excludes cardiac glycoside and excludes polysaccharide obtained from Nerium species or Thevetia species. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of the pharmaceutical composition to a subject.
Composition for and Method of Treating Neurological Conditions
A method of treating neurological condition in a subject by administration of a pharmaceutical composition that excludes cardiac glycoside and excludes polysaccharide obtained from Nerium species or Thevetia species. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of the pharmaceutical composition to a subject.
METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS
Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.
Method and Compositions for Treating Equine Encephalitis
A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
Method and Compositions for Treating Equine Encephalitis
A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC COMPOUNDS
New metered-dosing compositions and methods of use comprising at least one psychedelic compound derived from living organisms such as plants and fungi, synthetically-derived forms or synthetic analogue. The composition for use in metered-dosing administration modalities, including a nasal spray, pressurized metered-dose inhaler, etc.
METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC COMPOUNDS
New metered-dosing compositions and methods of use comprising at least one psychedelic compound derived from living organisms such as plants and fungi, synthetically-derived forms or synthetic analogue. The composition for use in metered-dosing administration modalities, including a nasal spray, pressurized metered-dose inhaler, etc.
Composition for antioxidation, anti-inflammation, or osteoclast differentiation inhibition
The present invention relates to a composition for antioxidation, anti-inflammation, or osteoclast differentiation inhibition and a composition for arthritis treatment, each of the compositions containing a fraction of a complex extract of Cynanchum wilfordii, Phlomis umbrosa, and Angelica gigas as an active ingredient. The compositions of the present invention can be effectively used for osteoclast differentiation inhibition, antioxidation, or anti-inflammation, and arthritis treatment.